Synapse - Amrita V Herkal

Amrita V Herkal

Research Focus

Former Employee. Research Service Centers; Technologist II

Recent additions – View all

Clinical validity of detecting circulating tumor cells by AdnaTest assay compared with direct detection of tumor mRNA in stabilized whole blood, as a biomarker predicting overall survival for metastatic castration-resistant prostate cancer patients
Journal Article

Danila, D. C.; Samoila, A.; Patel, C.; Schreiber, N.; Herkal, A.; Anand, A.; Bastos, D.; Heller, G.; Fleisher, M.; Scher, H. I.
The Cancer Journal (2016)

Fulltext@MSK | Save
Predictive biomarkers of tumor sensitivity to STEAP1 antibody-drug conjugate (ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Meeting Abstract

Danila, D. C.; Scher, H. I.; Szafer-Glusman, E.; Herkal, A.; Suttmann, R.; Fleisher, M.; Schreiber, N. A.; Curtis, K.; Gilbert, H.; Maslyar, D.; more...
Cancer Research (2015)

Fulltext@MSK | Save
STEAP1 as a predictive biomarker for antibody-drug conjugate (ADC) activity in metastatic castration resistant prostate cancer (mCRPC)
Meeting Abstract

Danila, D. C.; Fleisher, M.; Carrasquillo, J. A.; Gilbert, H.; Morris, M. J.; Bellomo, L. P.; Hendrikx, P. J.; Szafer-Glusman, E.; Herkal, A.; Patel, C.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Co-authors at MSK

7

Danila
7

Fleisher
7

Scher
5

Anand
4

Patel
4

Schreiber
3

Bastos
3

Curtis
3

Heller
3

Samoila
2

Khanin
2

Lilja
2

Schultz
1

Bellomo
1

Carrasq...
1

Hendrikx
1

Morris
1

Wan

Types of Work

Publications